Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Pneumonia × tocilizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Sarcoma, Kaposi 1 Respiratory Distress Syndrome 1 Pneumonia 1 Multi-centric Castleman's Disease 1 Hematologic Neoplasms 1 Glioblastoma 1 Castleman Disease 1 Astrocytoma 1 Acquired Immunodeficiency Syndrome 1

Interventions

tocilizumab 1 Methylprednisolone 1 Immunoglobulin G 1 Etanercept 1 Disulfides 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04370834 2025-02-04

Tocilizumab for Patients With Cancer and COVID-19 Disease

National Cancer Institute (NCI)

Phase 2 Terminated

1 enrolled 10 charts

Other hematologic neoplasm

Pneumonia, Respiratory Distress Syndrome, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡